Human Umbilical Cord-Mesenchymal Stem Cells for Rheumatoid Arthritis

• Status: Unknown status
• Trial end date: 2017-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the safety and efficacy of human umbilical cord mesenchymal stem cell(hUC-MSC) for Rheumatoid Arthritis.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Shenzhen Hornetcorn Bio-technology Company, LTD
• Collaborator: Futian People's Hospital
• Treatments: Antirheumatic Agents; Methotrexate

Criteria

Inclusion Criteria:

• Aged 18-80 Rheumatoid Arthritis patient;

• Patients must consent in writing to participate in the study by signing and dating an informed consent document;

• Patients must have a diagnosis of Rheumatoid Arthritis according to the 2010 ACR/EULAR criteria for at least 12 weeks duration;

• Stage I and II according to X-ray.

Exclusion Criteria:

• History of neurological disease, head injury or psychiatric disorder;

• Pregnant women;

• Impaired liver function, abnormal blood coagulation, AIDS, HIV, combine other tumor or special condition;

• Progressive apoplexy;

• With malignant tumors;

• Patients who had participated in other clinical trials within three months prior to this study.